Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comment on: Population pharmacokinetics of the rilpivirine long-acting formulation after intramuscular dosing in healthy subjects and people living with HIV.
Benaboud S, Solas C, Bouchet S, Gregoire M, Lemaitre F, Venisse N, Lê MP, Muret P, Parant F, Neant N, Boujafaar S, Lagoutte-Renosi J, Garraffo R, Peytavin G. Benaboud S, et al. Among authors: bouchet s. J Antimicrob Chemother. 2023 Mar 2;78(3):853-854. doi: 10.1093/jac/dkad009. J Antimicrob Chemother. 2023. PMID: 36683308 No abstract available.
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C; ANRS-AC43 Clinical Pharmacology Committee, SFPT Therapeutic Drug Monitoring and Treatment Personalization group. Venisse N, et al. Among authors: bouchet s. Antiviral Res. 2020 Sep;181:104866. doi: 10.1016/j.antiviral.2020.104866. Epub 2020 Jul 10. Antiviral Res. 2020. PMID: 32659293 Free PMC article. Review.
Management of drug-drug interactions with nirmatrelvir/ritonavir in patients treated for Covid-19: Guidelines from the French Society of Pharmacology and Therapeutics (SFPT).
Lemaitre F, Grégoire M, Monchaud C, Bouchet S, Saint-Salvi B, Polard E; SFPT Therapeutic Drug Monitoring and Treatment Personalization group (STP-PT) of the French Society of Pharmacology and Therapeutics (SFPT); French Pharmacovigilance Network (CRPV); ANRS-MIE AC-43 Clinical Pharmacology Committee, joint working group; SFPT Therapeutic Drug Monitoring and Treatment Personalization group (STP-PT) of the French Society of Pharmacology and Therapeutics (SFPT); French Pharmacovigilance Network (CRPV); ANRS-MIE AC-43 Clinical Pharmacology Committee, joint working group. Lemaitre F, et al. Among authors: bouchet s. Therapie. 2022 Sep-Oct;77(5):509-521. doi: 10.1016/j.therap.2022.03.005. Epub 2022 Apr 20. Therapie. 2022. PMID: 35618549 Free PMC article.
Neglecting Plasma Protein Binding in COVID-19 Patients Leads to a Wrong Interpretation of Lopinavir Overexposure.
Stanke-Labesque F, Concordet D, Djerada Z, Bouchet S, Solas C, Mériglier E, Bonnet F, Mourvillier B, Ruiz S, Martin-Blondel G, Epaulard O, Schwebel C, Gautier-Veyret E, Gandia P. Stanke-Labesque F, et al. Among authors: bouchet s. Clin Pharmacol Ther. 2021 Apr;109(4):1030-1033. doi: 10.1002/cpt.2196. Epub 2021 Mar 9. Clin Pharmacol Ther. 2021. PMID: 33547636 Free PMC article.
COVID-19 infection also occurs in patients taking hydroxychloroquine.
Lahouati M, Mériglier E, Martin L, Bouchet S, Desclaux A, Bonnet F. Lahouati M, et al. Among authors: bouchet s. J Antimicrob Chemother. 2020 Jul 1;75(7):2014-2015. doi: 10.1093/jac/dkaa193. J Antimicrob Chemother. 2020. PMID: 32417904 Free PMC article. No abstract available.
Safety of hydroxychloroquine and darunavir or lopinavir in COVID-19 infection.
Meriglier E, Rivoisy C, Hessamfar M, Bernard N, Aureau I, Lapoirie J, Contis A, Sacher F, Sacristan B, Lahouati M, Pedeboscq S, Vandenhende MA, Bouchet S, Bonnet F. Meriglier E, et al. Among authors: bouchet s. J Antimicrob Chemother. 2021 Jan 19;76(2):482-486. doi: 10.1093/jac/dkaa441. J Antimicrob Chemother. 2021. PMID: 33221868 Free PMC article.
Development of a Bayesian estimator for the therapeutic drug monitoring of mycophenolate mofetil in children with idiopathic nephrotic syndrome.
Saint-Marcoux F, Guigonis V, Decramer S, Gandia P, Ranchin B, Parant F, Bessenay L, Libert F, Harambat J, Bouchet S, Broux F, Compagnon P, Marquet P. Saint-Marcoux F, et al. Among authors: bouchet s. Pharmacol Res. 2011 May;63(5):423-31. doi: 10.1016/j.phrs.2011.01.009. Epub 2011 Jan 25. Pharmacol Res. 2011. PMID: 21272643
160 results